Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Mayo Clinic

Q3 2024 · 13F-HR

Mayo Clinicholdings as filed

Filed 2024-11-12 · accession 0000912282-24-000766

$2.9M
Reported value
3
Positions
2024-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
464288257ACWIISHARES TR$2.1M71.5%17,359CommonSOLE
98943L107ZNTLZentalis Pharmaceuticals Inc$644,00022.2%175,000CommonSOLE
91381U200UNBXUNITY BIOTECHNOLOGY INC$182,3996.29%124,081CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.